Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes

被引：0
|
作者：
Ohno, Yasuhiro [1 ]
Tanaka, Yoichi [1 ]
Fujimoto, Mika [1 ]
Maruyama, Yasunori [1 ]
机构：
[1] Kinki Univ, Sakai Hosp, Fac Med, Sakai, Osaka, Japan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-1052
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
    Crepaldi, G.
    Carruba, M.
    Comaschi, M.
    Del Prato, S.
    Frajese, G.
    Paolisso, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (07) : 610 - 614
  • [22] Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Pro
    Nauck, M. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (11) : 546 - 546
  • [23] The influence of DPP-4 inhibitors on fat metabolism in type 2 diabetes patients
    Ametov, A. S.
    Gusenbekova, D. G.
    DIABETOLOGIA, 2014, 57 : S378 - S378
  • [24] Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
    G. Crepaldi
    M. Carruba
    M. Comaschi
    S. Del Prato
    G. Frajese
    G. Paolisso
    Journal of Endocrinological Investigation, 2007, 30 : 610 - 614
  • [25] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    Prasad, Krishna
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [26] Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
    Deacon, Carolyn F.
    PEPTIDES, 2018, 100 : 150 - 157
  • [27] Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Contra
    Mueller, U. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (11) : 547 - 547
  • [28] The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
    Choe, Eun Yeong
    Cho, Yongin
    Choi, Younjeong
    Yun, Yujung
    Wang, Hye Jin
    Kwon, Obin
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    DIABETES & METABOLISM JOURNAL, 2014, 38 (03) : 211 - 219
  • [29] The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients
    Du, Hengzhi
    Wang, Dao Wen
    Chen, Chen
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (18) : 10274 - 10278
  • [30] Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
    Subrahmanyan, Nikhila A.
    Koshy, Rithika M.
    Jacob, Koshy
    Pappachan, Joseph M.
    CURRENT DRUG SAFETY, 2021, 16 (02) : 154 - 164
12345